161 related articles for article (PubMed ID: 28712819)
1. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
[TBL] [Abstract][Full Text] [Related]
2. Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples.
Chun JY; Jeong SJ; Kim S; Choi S; Lee JH; Chung HS; Park S; Lee H; Kim HY; Hwangbo B; Choi YJ
J Infect; 2024 Jun; 88(6):106159. PubMed ID: 38641139
[TBL] [Abstract][Full Text] [Related]
3. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
[TBL] [Abstract][Full Text] [Related]
4. Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis.
Fisher CE; Stevens AM; Leisenring W; Pergam SA; Boeckh M; Hohl TM
Transpl Infect Dis; 2014 Jun; 16(3):505-10. PubMed ID: 24725139
[TBL] [Abstract][Full Text] [Related]
5. Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
Egger M; Penziner S; Dichtl K; Gornicec M; Kriegl L; Krause R; Khong E; Mehta S; Vargas M; Gianella S; Porrachia M; Jenks JD; Venkataraman I; Hoenigl M
J Clin Microbiol; 2022 Apr; 60(4):e0021522. PubMed ID: 35350844
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
[TBL] [Abstract][Full Text] [Related]
7. Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
Acet-Öztürk NA; Ömer-Topçu D; Vurat Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Özkalemkaş F; Ener B; Ali R; Akalın H
Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):33-43. PubMed ID: 37910269
[TBL] [Abstract][Full Text] [Related]
8. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
D'Haese J; Theunissen K; Vermeulen E; Schoemans H; De Vlieger G; Lammertijn L; Meersseman P; Meersseman W; Lagrou K; Maertens J
J Clin Microbiol; 2012 Apr; 50(4):1258-63. PubMed ID: 22301025
[TBL] [Abstract][Full Text] [Related]
9. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological Malignancy.
Das S; Capoor MR; Singh A; Agarwal Y
Mycopathologia; 2023 Dec; 188(6):1055-1063. PubMed ID: 37806994
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the JF5-based Aspergillus galactomannoprotein lateral flow device for diagnosing invasive aspergillosis in cancer patients.
Wan L; Cai X; Ling M; Kan J; Yin M; Wang H
Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1221-1229. PubMed ID: 38625450
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.
Zhang S; Wang S; Wan Z; Li R; Yu J
Biomed Res Int; 2015; 2015():943691. PubMed ID: 25685819
[TBL] [Abstract][Full Text] [Related]
13. Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial.
Xiao W; Gong DY; Mao B; Du XM; Cai LL; Wang MY; Fu JJ
BMC Infect Dis; 2018 Jun; 18(1):271. PubMed ID: 29890956
[TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
[TBL] [Abstract][Full Text] [Related]
15. Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients.
Zhu N; Zhou D; Xiong W; Zhang X; Li S
Front Cell Infect Microbiol; 2023; 13():1271853. PubMed ID: 38029249
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases.
Han SB; Kim SK; Bae EY; Lee JW; Yoon JS; Chung NG; Cho B; Jeong DC; Kang JH; Kim HK; Lee DG; Lee HS; Im SA
J Korean Med Sci; 2015 Aug; 30(8):1121-8. PubMed ID: 26240490
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients.
Ao Z; Xu H; Li M; Liu H; Deng M; Liu Y
BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36828645
[TBL] [Abstract][Full Text] [Related]
18. Metagenomic next-generation sequencing for detecting
Shi Y; Peng JM; Hu XY; Yang QW; Wang Y
Front Cell Infect Microbiol; 2023; 13():1209724. PubMed ID: 38188627
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies.
Gupta A; Capoor MR; Shende T; Sharma B; Mohindra R; Suri JC; Gupta DK
J Lab Physicians; 2017; 9(4):234-238. PubMed ID: 28966482
[TBL] [Abstract][Full Text] [Related]
20. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
Ader F; Bienvenu AL; Rammaert B; Nseir S
Int J Chron Obstruct Pulmon Dis; 2009; 4():279-87. PubMed ID: 19684861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
